Literature DB >> 10666096

Ventricular adrenomedullin concentration is a sensitive biochemical marker for volume and pressure overload in rats.

F Yoshihara1, T Nishikimi, T Horio, C Yutani, N Nagaya, H Matsuo, T Ohe, K Kangawa.   

Abstract

This study was designed to investigate the pathophysiological significance of adrenomedullin (AM) concentration in volume- and pressure-overloaded cardiac hypertrophy. We measured ventricular AM concentrations and compared them with changes of alpha-actin and myosin heavy chain (MHC) mRNA isoforms after the creation of an aortocaval (AC) shunt as a volume-overload model or the injection of monocrotaline (MCT) as a pressure-overload model, respectively. The left ventricular AM levels after the creation of AC shunt and the right ventricular AM levels after the injection of MCT were significantly increased and correlated with changes of the alpha-actin and MHC mRNA isoforms. However, the ventricular AM mRNA expressions were increased and correlated with ventricular AM concentrations only in the AC shunt model. These results suggest that the ventricular AM levels are upregulated in both the volume- and pressure-overloaded cardiac hypertrophy by differential transcriptional regulation and that the ventricular AM may be a biochemical marker for the volume and pressure overload to the ventricle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666096     DOI: 10.1152/ajpheart.2000.278.2.H633

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  2 in total

1.  Increased pericardial fluid concentrations of the mature form of adrenomedullin in patients with cardiac remodelling.

Authors:  K Tambara; M Fujita; N Nagaya; S Miyamoto; A Iwakura; K Doi; G Sakaguchi; K Nishimura; K Kangawa; M Komeda
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

2.  Increase in plasma adrenomedullin in patients with heart failure characterised by diastolic dysfunction.

Authors:  C M Yu; B M Cheung; R Leung; Q Wang; W H Lai; C P Lau
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.